XJPX4483
Market cap1.61bUSD
Dec 27, Last price
3,883.00JPY
1D
2.45%
1Q
-18.01%
IPO
106.82%
Name
JMDC Inc
Chart & Performance
P/E
55.09
P/S
7.84
EPS
70.48
Div Yield, %
0.30%
Shrs. gr., 5y
7.19%
Rev. gr., 5y
26.33%
Revenues
32.38b
+16.44%
Net income
4.61b
+7.97%
CFO
-17m
L
Dividend
Mar 28, 202414 JPY/sh
Profile
JMDC Inc. provides medical statistics data services in Japan. The company operates through three segments: Healthcare-Big Data, Telemedicine, and Dispensing Pharmacy Support. It offers medical field big data services; life insurance field big data services; support services for health insurance associations and local government health services; health data platform; and medical institution support services. The company also provides remote image interpretation matching services and ASP services for remote image interpretation system; and develops and sells business systems for dispensing pharmacies. It serves health insurance unions, pharmaceutical companies, life and non-life insurance companies, research institutions, etc. The company was incorporated in 2002 and is headquartered in Tokyo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||
Revenues | 32,381,000 16.44% | 27,809,000 27.48% | 21,814,000 30.07% | |||||
Cost of revenue | 25,329,000 | 22,552,000 | 17,491,000 | |||||
Unusual Expense (Income) | ||||||||
NOPBT | 7,052,000 | 5,257,000 | 4,323,000 | |||||
NOPBT Margin | 21.78% | 18.90% | 19.82% | |||||
Operating Taxes | 2,280,000 | 1,601,000 | 1,532,000 | |||||
Tax Rate | 32.33% | 30.45% | 35.44% | |||||
NOPAT | 4,772,000 | 3,656,000 | 2,791,000 | |||||
Net income | 4,607,000 7.97% | 4,267,000 31.41% | 3,247,000 31.14% | |||||
Dividends | (754,000) | (564,000) | ||||||
Dividend yield | 0.32% | 0.20% | ||||||
Proceeds from repurchase of equity | 2,202,000 | 50,645,000 | 225,000 | |||||
BB yield | -0.93% | -17.65% | -0.06% | |||||
| Debt | ||||||||
Debt current | 23,438,000 | 1,840,000 | 1,466,000 | |||||
Long-term debt | 23,298,000 | 26,027,000 | 22,419,000 | |||||
Deferred revenue | 1,535,000 | 1,520,000 | 1,560,000 | |||||
Other long-term liabilities | 904,000 | 1,018,000 | 597,000 | |||||
Net debt | 27,722,000 | (3,000) | 6,693,000 | |||||
| Cash flow | ||||||||
Cash from operating activities | (17,000) | 4,062,000 | 3,808,000 | |||||
CAPEX | (893,000) | (1,940,000) | (1,322,000) | |||||
Cash from investing activities | (24,864,000) | (22,769,000) | (8,101,000) | |||||
Cash from financing activities | 16,581,000 | 28,296,000 | (2,414,000) | |||||
FCF | (12,879,000) | (379,000) | 2,498,000 | |||||
| Balance | ||||||||
Cash | 14,473,000 | 26,122,000 | 15,753,000 | |||||
Long term investments | 4,541,000 | 1,748,000 | 1,439,000 | |||||
Excess cash | 17,394,950 | 26,479,550 | 16,101,300 | |||||
Stockholders' equity | 42,385,000 | 37,316,000 | 18,694,000 | |||||
Invested Capital | 93,561,050 | 59,780,450 | 34,027,700 | |||||
ROIC | 6.22% | 7.79% | 8.45% | |||||
ROCE | 6.32% | 6.04% | 8.49% | |||||
| EV | ||||||||
Common stock shares outstanding | 65,868 | 63,051 | 59,965 | |||||
Price | 3,609.00 -20.68% | 4,550.00 -32.69% | 6,760.00 29.50% | |||||
Market cap | 237,717,608 -17.14% | 286,882,050 -29.23% | 405,363,400 36.37% | |||||
EV | 265,535,608 | 286,865,050 | 412,051,400 | |||||
EBITDA | 9,289,000 | 7,273,000 | 5,992,000 | |||||
EV/EBITDA | 28.59 | 39.44 | 68.77 | |||||
Interest | 114,000 | 88,000 | 62,000 | |||||
Interest/NOPBT | 1.62% | 1.67% | 1.43% | |||||